Tango Therapeutics, Inc. (NASDAQ:TNGX) Financings

Tango Therapeutics, Inc.

Financings

RaiseDate
Public offering of common stock and pre-funded warrants
Announced: about US$600M · US$30 a share · J.P. Morgan +3
Dealers: J.P. Morgan (co-lead), Leerink Partners (co-lead), Cantor (co-lead), Stifel (co-lead)
Jun 10, 2026
Public offering of common stock and pre-funded warrants
Announced: about US$210M · US$8.66 a share · Leerink Partners +1
Dealers: Leerink Partners (co-lead), Cantor (co-lead)
Buyers: Farallon Capital Management; TCGX; Balyasny Asset Management; Woodline Partners LP; Invus; Adage Capital Management LP; Boxer Capital Management; Logos Capital; Nantahala Capital; accounts advised by T. Rowe Price Investment Management, Inc.
Oct 23, 2025
Private placement of common stock
Announced: about US$15M · US$8.66 a share
Buyers: Nextech (led the PIPE)
Oct 23, 2025

Read by 6ix AI from the company's releases